MedPath

Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer

Terminated
Conditions
Metastatic Breast Cancer
Interventions
Procedure: Bone marrow aspirates and biopsy
Registration Number
NCT01975597
Lead Sponsor
University of Michigan Rogel Cancer Center
Brief Summary

This is a feasibility study to demonstrate the team's ability to collect bone marrow aspirates and biopsies for research purposes from women with metastatic breast cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • Patients with metastatic breast cancer (any site) age 21 or older
  • Patients willing and able to provide informed consent & perform study procedures
  • Patients may enroll with recently (with 2 months) progressive tumor burden
  • Performance status of 0,1 or 2
Exclusion Criteria
  • Patients unable or unwilling to provide informed consent and or perform study procedures
  • Patients with active, uncontrolled coagulopathy
  • Patients on treatment dose anticoagulation or an International Normalised Ratio of 2 or greater if on warfarin
  • Patients who are known to be pregnant are not eligible to participate in this study during the time of the pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Bone marrow aspirates and biopsyBone marrow aspirates and biopsy-
Primary Outcome Measures
NameTimeMethod
Number of patient that agree to undergo 2 biopsy's strictly for research purposes.At 3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath